CTEV
Claritev Corporation
NYSE: CTEV · HEALTHCARE · HEALTH INFORMATION SERVICES
$24.33
+5.51% today
Updated 2026-04-30
Market cap
$403.98M
P/E ratio
—
P/S ratio
0.42x
EPS (TTM)
$-17.30
Dividend yield
—
52W range
$12 – $74
Volume
0.2M
Claritev Corporation (CTEV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-29.40%
Operating margin
9.77%
ROE
-646.00%
ROA
1.12%
Debt/equity
-45.69x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $1.04B | $36.22M | 85.64% | 41.07% | 3.48% |
| 2019 | $982.90M | $9.71M | 84.78% | 37.46% | 0.99% |
| 2020 | $937.76M | $-520.56M | 66.02% | -14.06% | -55.51% |
| 2021 | $1.12B | $102.08M | 84.32% | 34.55% | 9.13% |
| 2022 | $1.08B | $-572.91M | 81.10% | -33.60% | -53.06% |
| 2023 | $961.52M | $-91.70M | 75.51% | 16.85% | -9.54% |
| 2024 | $930.62M | $-1.65B | 74.27% | -149.35% | -176.85% |
| 2025 | $965.41M | $-284.28M | 27.61% | 4.67% | -29.45% |